Aduhelm Approval Boosts Other Alzheimer’s Drug Developers

Even Companies Not Focused On Clearing Amyloid Benefitted

 
• By Mandy Jackson
  
Alzheimer's and dementia research, a brain scan in multi well tray used for research experiments in laboratory
Investment in Alzheimer's R&D should get a boost from Aduhelm's approval • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip